UTHR
United Therapeutics Corporation
Stock
$541.70−29.68 (−5.19%)Close Oct 2, 2026
Key figures
| Metric | Last 12 months | 5-year CAGR |
|---|---|---|
| Revenue | $3.2B | +16.5% |
| Gross profit | $2.7B | +15.3% |
| Operating income | $1.4B | +20.2% |
| Net income | $1.3B | +21.0% |
| EPS | $27.94 | +19.3% |
| Free cash flow | $1.1B | +8.4% |